From April 15, 2024 to May 22, 2024, the company has repurchased 1,247,200 shares, representing 0.27% for CNY 49.99 million. With this, the company has completed the repurchase of 1,247,200 shares, representing 0.27% for CNY 49.99 million under the buyback announced on April 15, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.6 CNY | +2.23% | -2.17% | -57.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.49% | 1.7B | |
-18.64% | 8.46B | |
+71.50% | 4.41B | |
+11.92% | 2.88B | |
-2.80% | 2.64B | |
-16.07% | 1.73B | |
-16.46% | 1.5B | |
-49.06% | 1.03B | |
+16.62% | 968M | |
-16.56% | 878M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on April 15, 2024.